Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 9, 1997, Pages 4620-4625

  Waisman, A ^a   Ruiz, P J ^a   Israeli, E ^a   Eilat, E ^a   Konen Waisman, S ^a   Zinger, H ^a   Dayan, M ^a   Mozes, E ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; NEWBORN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030940121     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.9.4620     Document Type: Article

References (30)